API Holdings Limited formerly known as ‘PharmEasy’is established in 2019. Siddharth Shah, Harsh Parekh, Hardik Dedhia, Dharmil Sheth and Dhaval Shah are the company promoters.
PharmEasy IPO: API Holdings operate an integrated, end-to-end business that aims to provide solutions for healthcare needs of consumers across the following critical stages. A. providing digital tools and information on illness and wellness, B. offering teleconsultation,
C. offering diagnostics and radiology tests, and D. delivering treatment protocols including products and devices.
They have working in online as well as offline industries with their brands like Docon, PharmEasy, Medlife, Thyrocare, Aknamed, Marg ERP Limited (49.17% stake),redbook, retailio.
Requirement of funds
- 1. Prepayment or repayment of all or a portion of certain outstanding borrowings availed by our Company and certain
of our Subsidiaries; - 2. Funding organic growth initiatives;
- 3. Pursuing inorganic growth through acquisitions and other strategic initiatives; and
- 4. General corporate purposes.
The company will use 1,929 ₹ crore from the IPO proceeds to repay or prepay borrowings and 1,259 ₹ crore to fund organic growth initiatives. It will also allocate ₹1,500 crore on inorganic growth opportunities through acquisitions and other strategic initiatives.
Read : Upcoming IPO
| PharmEasy IPO Details | |
| IPO Opening Dates | Update Soon |
| IPO Closing Dates | Update Soon |
| Price Band | Update Soon |
| Offer For Sale | Update Soon |
| Fresh issue | Update Soon |
| Total size | 6250 Crore |
| Minimum bid (lot size) | Update Soon |
| Face Value | 1 Rs share |
| Retail Allocation | 10% |
| QIB Allocation | 75% |
| NII Allocation | 15% |
| Listing On | NSE, BSE |
| PharmEasy IPO Market Lot | |||
| Lot | No of Shares | Amount | |
| Minimum | Update Soon | Update Soon | Update Soon |
| Maximum | Update Soon | Update Soon | Update Soon |
Financial Record of the last year (In Millions)
Financial Period : 30-Jun-21
Total Assets : 980.39
Total Revenue : 11,968.08
Loss After Tax : (3,138.91)
Earnings Per Share (EPS) FY2021 : (77.20) INR
PharmEasy IPO DRHP
PharmEasy IPO Review
Avoid (Based on Financial Information)
PharmEasy IPO Allotment Date & Details
| Allotment Date | Update Soon |
| Initiation of refunds | Update Soon |
| Transfer of shares to Demat accounts | Update Soon |
| Listing Date | Update Soon |
Registrar of PharmEasy
Link Intime India Private Limited
C-101, 247 Park, L B S Marg,
Vikhroli (West), Mumbai 400 083,
Maharashtra, India
Tel: +91 22 4918 6000
E-mail: [email protected]
Website: www.linkintime.co.in
SEBI Registration No.:INR000004058
PharmEasy Contact Details
902, 9th Floor, Raheja Plaza 1,
B-Wing, Opposite R-City Mall,
L.B.S. Marg, Ghatkopar West,
Mumbai 400 086, Maharashtra,
India; Tel: +91 22 6255 6255;
Website: www.apiholdings.in;
Corporate Identity Number: U60100MH2019PLC323444
PharmEasy IPO Lead Managers
Kotak Mahindra Capital Company Limited
Morgan Stanley India Company Private Limited
BofA Securities India Limited
Citigroup Global Markets India Private Limited
JM Financial Limited